子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 121 | Compound and color filter | US13636888 | 2011-09-21 | US08404894B2 | 2013-03-26 | Hitoshi Kondou; Shougo Yamada; Ryousuke Asami; Katsunori Shimada |
| There is provided a triarylmethane compound which can provide a colored product that has light resistance equivalent to heretofore available light resistance and that undergoes only a small change in hue over a long period of time even when having a high-temperature heat history. For example, when a blue pixel portion of a color filter is formed, there is provided a triarylmethane compound which can provide a liquid crystal display apparatus or the like that has light resistance equivalent to heretofore available light resistance and that can perform high-brightness liquid crystal display for a long time even at high temperature. There is also provided a color filter containing the triarylmethane compound in the blue pixel portion. In the triarylmethane compound, the counter-anion of a basic triarylmethane dye cation is a heteropolyoxometalate anion represented by (SiMoW11O40)4−/4. The color filter contains the triarylmethane compound in a blue pixel portion. | ||||||
| 122 | Method for preparation of N-methyl-3-(2-tributylstannylphenoxy)-3-phenylpropanamine, and use therof | US13087862 | 2011-04-15 | US08258331B2 | 2012-09-04 | Show-Wen Liu; Cheng-Hsien Lin; Tsyh-Lang Lin; Cheng-Fang Hsu; Yu Chang |
| A method for preparation of N-methyl-3-(2-tributylstannylphenoxy)-3-phenylpropanamine is provided, which includes formation of N-methyl-3-(2-tributylstannylphenoxy)-3-phenylpropanamine, useful as a precursor of a norepinephrine transporter (NET) contrast label [123Iodine](R)—N-methyl-3-(2-iodophenoxy)-3-phenylpropanamine ([123I]MIPP) with a leaving group Bu3Sn. | ||||||
| 123 | Macromolecular antioxidants comprising differing antioxidant moieties: structures, methods of making and using the same | US12319282 | 2009-01-05 | US08039673B2 | 2011-10-18 | Ashok L. Cholli; Rajesh Kumar |
| Described are antioxidant macromolecules and methods of making and using same. | ||||||
| 124 | Additive and vehicle for inks, paints, coatings and adhesives | US11009577 | 2004-12-10 | US07863485B2 | 2011-01-04 | Leroy John Cook; Richard T. Skov |
| An environmentally safe additive and vehicle system are provided for water-based and oil-based printing inks, paints, coatings and adhesives which can be rapidly transferred, dispersed, dispensed, spread, dried and cured. The low cost, stable additive and vehicle system enhance multiple color, high speed printing with sharp, highly defined images and superior quality, and can be used on many different types of substrates, such as paper, paperboard, cardboard, clay coated board, foil, plastic, glass, metal, wood and composites. The additive may be formed by the reaction product of a photoinitiator, such as an UV-activated polyelectrolyte, and a monomer, such as an acrylate or a methacrylate in an aqueous solution. In other embodiments, the additive is formed from a carboxylic acid or anhydride and alkylalkanolamine monomer or a dialkylaminoalkyl acrylate or methacrylate monomer in an aqueous solution. | ||||||
| 125 | DETECTION OF ESR1 AMPLIFICATION IN BREAST CANCER | US12305258 | 2007-06-26 | US20100086915A1 | 2010-04-08 | Guido Sauter; Ronald Simon; Philip Stahl; Frederik Holst; Khawla A-Kuraya; Christian Ruiz |
| The present invention relates to an in-vitro method of identifying a tumor resulting from a proliferative breast disease as responsive to anti-estrogen treatment. Further, the invention relates to an in-vitro method of identifying a candidate patient with a proliferative breast disease as suitable for anti-estrogen treatment. In a further aspect, the invention provides an in-vitro method of identifying an individual with a non-cancerous proliferative breast disease who is at risk of developing breast cancer. The invention also provides kits for performing the above methods. | ||||||
| 126 | Polyoxyalkylene ammonium salts and their use as antistatic agents | US11781557 | 2007-07-23 | US07678941B2 | 2010-03-16 | Patricia M. Savu; William M. Lamanna; Thomas P. Klun |
| The present invention provides polyoxyalkylene ammonium imide or methide salts and their use as antistatic agents. Another embodiment provides articles comprising these salts, and processes for making and using these salts. | ||||||
| 127 | Diamine β2 adrenergic receptor agonists | US11143075 | 2005-06-02 | US07402673B2 | 2008-07-22 | Martin S. Linsell |
| The invention provides novel β2 adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds. | ||||||
| 128 | Method for purifying gases | US11217758 | 2005-09-01 | US20060045830A1 | 2006-03-02 | Horst Streitberger; Oliver Pfueller; Achim Stankowiak; Alexander Snell; Norbert Mollekopf; Hans-Dieter Mueller |
| The invention relates to the use of an absorption liquid for purifying gases from gaseous acidic contaminants, the absorption liquid comprising A) 0.1 to 100% by weight of one or more amines of the formula I where R1 is H, C1-C6-alkyl, an aromatic radical having 6 to 18 carbon atoms or a radical of the formula 2 R2 is H, C1-C6-alkyl, an aromatic radical having 6 to 18 carbon atoms or a radical of the formula 3 R3 is C1-C6-alkyl or an aromatic radical having 6 to 18 carbon atoms R4 is H or CH3 R5 is H or CH3 x is a number from 0 to 3 y is a number from 0 to 3 z is an integer between 1 and 30, and also, if appropriate, B) 0 to 99.9% by weight of water, and/or C) 0 to 99.9% by weight of any desired solvent. | ||||||
| 129 | Process for preparing isomers of salbutamol | US10450155 | 2001-12-10 | US06995286B2 | 2006-02-07 | Yusuf Khwaja Hamied; Rajendra Narayanrao Kankan; Dharmaraj Ramachandra Rao |
| A process for making optically pure (R) and (S) salbutamol comprises obtaining the (R) or (S) isomer of either salbutamol or a salbutamol precursor in substantially optically pure form by resolving a racemic or optically impure mixture of enantiomers of salbutamol or of said precursor with either (L) or (D) tartaric acid, and where necessary converting said isomer of said precursor into either (R or (S) salbutamol respectively; then optionally converting said optically pure (R) and/or (S) salbutamol into a pharmaceutically acceptable salt. | ||||||
| 130 | Vase-added compositions for controlling plant and flower moisture transpiration rates | US09760037 | 2001-01-12 | US20010042341A1 | 2001-11-22 | Mark William Hamersky; Steven Daryl Smith |
| The present invention relates to compositions for controlling plant and flower moisture transpiration and thereby extending the period of time in which cut flowers can be displayed before senescence produces a flower which has exceeded its aesthetic value. The compositions of the present invention comprise: a) from about 0.1% by weight, of a source of energy; b) from about 5 ppm by weight, of one or more antimicrobials; c) from about 1 ppm by weight, of a buffer; and d) the balance carriers and adjunct ingredients. | ||||||
| 131 | Fuel compositions containing etheramine alkoxylates | US105773 | 1998-06-26 | US6063145A | 2000-05-16 | John M. Larkin; Wei-Yang Su; Terry L. Renken |
| This invention concerns a fuel additive comprising an etheramine alkoxylate, and fuel compositions and additive concentrates made therefrom. The etheramine alkoxylate may be of formula: ##STR1## where R.sup.1 is a straight or branched alkyl, or alkylaryl; R.sup.2 is independently in each occurrence hydrogen or alkyl from 1 to 6 carbons; R.sup.3 is independently in each occurrence hydrogen or alkyl of from 1 to 6 carbons; m averages from about 2 to about 20; and x and y each independently average from about 0 to 2, where x+y averages from about 1 to about 4. | ||||||
| 132 | Method for the treatment of CNS disorders | US265610 | 1999-03-10 | US5985322A | 1999-11-16 | Neil R. Anderson; Roger F. Harrison; Daniel F. Lynch; Peter L. Oren |
| An improved method for the treatment of central nervous system disorders comprises treating patients with an enteric fluoxetine formulation. | ||||||
| 133 | Substituted basic 2-aminotetralin in pharmaceuticals | US131267 | 1993-10-01 | US5463105A | 1995-10-31 | Rudolf Schohe; Thomas Glaser; Jorg Traber; George S. Allen |
| For treatment of disorders of the central nervous system, the cardiovascular system or the intestinal tract, the new substituted basic 2-aminotetralins of the formula ##STR1## in which R.sup.1 represents hydrogen or alkyl,R.sup.2 represents hydrogen, alkyl or acyl, andR.sup.3 represents quinuclidine or a group of the formula--(CH.sub.2).sub.a --R.sup.4, --CH.sub.2 --CH.dbd.CH--(CH.sub.2).sub.b --R.sup.4, --CH.sub.2 --C.tbd.C--(CH.sub.2).sub.b --R.sup.4, ##STR2## wherein a denotes a number from 1 to 10,b denotes a number 0, 1, 2, 3 or 4,c denotes a number 0, 1 or 2,d denotes a number 2 or 3, andX denotes oxygen, sulphur or NR.sup.5, and their salts. | ||||||
| 134 | Phenoxyalkylamine and agricultural and horticultural bactericide | US35903 | 1993-03-23 | US5409957A | 1995-04-25 | Mitsunori Oda; Kazutoshi Kikkawa; Akinori Tanaka; Satoko Imaruoka; Shigeo Yoshinaka |
| Disclosed are a phenoxyalkylamine represented by the following general formula I and a salt of said phenoxyalkylamine represented by the following general formula II: ##STR1## wherein R represents a linear saturated hydrocarbon having 7 to 12 carbon atoms, n is an integer of from 1 to 5, m is an integer of from 2 to 4, and HX represents a mineral acid.These compounds have strong bacteriostatic and bactericidal actions for plants with no phytotoxicity. Therefore, these compounds are effectively used as the active ingredient of an agricultural and horticultural bactericide. | ||||||
| 135 | US13037387 | 1987-12-08 | US4880802B1 | 1994-01-25 | RUDOLF SCHOHE; THOMAS GLASER; JOERG TRABER; GEORGE S. ALLEN | |
| 136 | Process for the preparation of 5-hydroxydiprafenone and its acid addition salts | US164384 | 1988-03-04 | US5120874A | 1992-06-09 | Gerd Petrik; Klemens Schubert |
| A process for the preparation of 5-hydroxydiprafenone and its acid addition salts by catalytic removal of the benzyl group of the corresponding 5-benzyloxy compound is described. | ||||||
| 137 | Substituted basic 2-aminotetralin in pharmaceuticals | US378733 | 1989-07-12 | US5026857A | 1991-06-25 | Rudolf Schohe; Thomas Glaser; Jorg Traber; George S. Allen |
| For treatment of disorders of the central nervous system, the cardiovascular system or the intestinal tract, the new substituted basic 2-aminotetralins of the formula ##STR1## in which R.sup.1 represents hydrogen or alkyl,R.sup.2 represents hydrogen, alkyl or acyl, andR.sup.3 represents quinuclidine or a group of the formula --(CH.sub.2).sub.a --R.sup.4, --CH.sub.2 --CH.dbd.CH--(CH.sub.2).sub.b --R.sup.4, --CH.sub.2 C.tbd.C--(CH.sub.2).sub.b --R.sup.4, ##STR2## wherein a denotes a number from 1 to 10,b denotes a number 0, 1, 2, 3 or 4,c denotes a number 0, 1 or 2,d denotes a number 2 or 3, andx denotes oxygen, sulphur or NR.sup.5,and their salts. | ||||||
| 138 | Fluorinated bisaryloxy-substituted alkenes, process for their preparation and their use | US347595 | 1989-05-04 | US4990633A | 1991-02-05 | Michael Negele; Dietmar Beilefeldt; Thomas Himmler; Albrecht Marhold |
| New fluorinated bisaryloxy-substituted alkenes are prepared by reaction of substituted phenols with perhaloalkenes and can be used as electrical insulating agents. | ||||||
| 139 | 2,4-Diamino-1,3,5-trimethoxybenzene, process for its preparation and its use as a coupler in oxidation dyes for keratinous fibres | US212318 | 1988-04-27 | US4891045A | 1990-01-02 | Alex Junino; Jean J. Vandenbossche; Herve Borowiak; Gerard Lang |
| The invention relates to 2,4-diamino-1,3,5-trimethoxybenzene, a process for its preparation by catalytic reduction of 2,4-dinitro-1,3,5-trimethoxybenzene, and to its use, as a coupler, in combination with at least one oxidation dye precursor of the para type, for dyeing keratinous fibres and particularly human hair.The hair dyeing compositions according to the invention contain, in a cosmetically acceptable aqueous substrate, 0.05 to 3.5% by weight of 2,4-diamino-1,3,5-trimethoxybenzene or one of its salts, which imparts strong blue colors to hair when it is combined with p-phenylenediamines, or red colors when it is combined with p-aminophenols, in an alkaline oxidizing medium. | ||||||
| 140 | Tetrahydronaphthalene derivatives | US786253 | 1985-10-10 | US4680310A | 1987-07-14 | Urs Hengartner; Henri Ramuz |
| Tetrahydronaphthalene derivatives of the formula ##STR1## wherein Y, m, n, R and R.sup.1 to R.sup.9 are as set forth herein, are described.These compounds have a pronounced calcium-antagonistic and anti-arrhythmic activity and can accordingly be used as medicaments, especially for the control or prevention of angina pectoris, ischaemia, arrhythmias and high blood pressure. The compounds of formula I can be prepared by the amination of a compound of the formula ##STR2## with a corresponding N-methyl-phenylalkylamine and optional subsequent O-acylation. Compounds of formula II and IV are also described and are within the scope of the invention. | ||||||
QQ群二维码
意见反馈
意见反馈